| Untargeted metabolomics of breast cancer cells MCF-7 and SkBr3 treated with tamoxifen/trastuzumab BM Sharaf, AD Giddey, H Alniss, HM Al-Hroub, R El-Awady, M Mousa, ... Cancer genomics & proteomics 19 (1), 79-93, 2022 | 18 | 2022 |
| Skin cancer metabolic profile assessed by different analytical platforms YA Hagyousif, BM Sharaf, RA Zenati, W El-Huneidi, Y Bustanji, ... International Journal of Molecular Sciences 24 (2), 1604, 2023 | 9 | 2023 |
| Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab BM Sharaf, AD Giddey, HM Al-Hroub, V Menon, J Okendo, R El-Awady, ... Cancer chemotherapy and pharmacology 90 (6), 467-488, 2022 | 6 | 2022 |
| Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach NC Soares, A Ali, V Srinivasulu, BM Sharaf, AD Giddey, J Okendo, ... Journal of Proteomics 265, 104660, 2022 | 3 | 2022 |
| Integrated multi‐omics analysis reveals unique signatures of paclitaxel‐loaded poly(lactide‐co‐glycolide) nanoparticles treatment of head and neck cancer cells M Haider, J Jagal, K Bajbouj, BM Sharaf, L Sahnoon, J Okendo, ... Proteomics 23 (16), 2200380, 2023 | | 2023 |
| Untargeted Metabolomics Reveals Unique Biomolecular Signatures in Overweight and Obesity Using UHPLC-ESI-QTOF-MS Analysis AM Almehdi, FM Al-Daffaie, BM Sharaf, A Guella, NC Soares, ... | | |
